Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAvadel Pharmaceuticals plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.09 | -$0.03 | -$0.06 |
| Q2 2025 | 2 | -$0.00 | -$0.00 | -$0.00 |
| Q3 2025 | 2 | $0.06 | $0.07 | $0.07 |
| Q4 2025 | 2 | $0.11 | $0.13 | $0.12 |
| Q1 2026 | 1 | $0.06 | $0.06 | $0.06 |
| Q2 2026 | 1 | $0.13 | $0.14 | $0.14 |
| Q3 2026 | 1 | $0.16 | $0.18 | $0.17 |
| Q4 2026 | 1 | $0.22 | $0.24 | $0.23 |
Avadel Pharmaceuticals plc Earnings Date And Information
Avadel Pharmaceuticals plc last posted its earnings results on Monday, March 3rd, 2025. The company reported $-0.05 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0. The company had revenue of 50.41 M for the quarter and had revenue of 169.12 M for the year. Avadel Pharmaceuticals plc has generated $-1 earnings per share over the last year ($-0.51 diluted earnings per share) and currently has a price-to-earnings ratio of -16.56. Avadel Pharmaceuticals plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 8th, 2025 based on prior year's report dates.
Avadel Pharmaceuticals plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/03/2025 | Q4 2024 | -$0.05 | -$0.05 | -0 | $50.00 M | $50.41 M |
| 11/12/2024 | Q3 2024 | -$0.06 | -$0.03 | 0.03 | $48.43 M | $50.03 M |
| 08/08/2024 | Q2 2024 | -$0.17 | -$0.14 | 0.03 | $37.47 M | $41.50 M |
| 05/08/2024 | Q1 2024 | -$0.25 | -$0.30 | -0.05 | N/A | $27.18 M |
| 02/29/2024 | Q4 2023 | N/A | -$0.30 | N/A | $18.19 M | $19.45 M |
| 11/08/2023 | Q3 2023 | -$0.35 | -$0.41 | -0.06 | $5.12 M | $7.01 M |
| 08/09/2023 | Q2 2023 | -$0.39 | -$0.83 | -0.44 | $361,333 | $1.50 M |
| 05/04/2023 | Q1 2023 | -$0.37 | -$0.48 | -0.11 | N/A | $0 |
| 03/29/2023 | Q4 2022 | N/A | -$0.43 | N/A | N/A | $0 |
| 11/09/2022 | Q3 2022 | -$0.22 | -$0.33 | -0.11 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$0.41 | -$1.07 | -0.66 | N/A | $0 |
| 05/09/2022 | Q1 2022 | -$0.44 | -$0.45 | -0.01 | N/A | $0 |
| 03/16/2022 | Q4 2021 | N/A | -$0.38 | N/A | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.38 | -$0.38 | 0 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.31 | -$0.33 | -0.02 | N/A | $0 |
| 05/10/2021 | Q1 2021 | -$0.32 | -$0.23 | 0.09 | N/A | $0 |
| 03/09/2021 | Q4 2020 | -$0.28 | -$0.19 | 0.09 | N/A | $0 |
| 11/09/2020 | Q3 2020 | -$0.26 | -$0.20 | 0.06 | N/A | $14.23 M |
| 08/10/2020 | Q2 2020 | -$0.18 | $0.57 | 0.75 | $7.92 M | $10.09 M |
| 05/11/2020 | Q1 2020 | -$0.27 | -$0.02 | 0.25 | N/A | $12.24 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avadel Pharmaceuticals plc Earnings: FAQ's
Avadel Pharmaceuticals plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 8th, 2025 based offlast year's report dates.
The conference call for Avadel Pharmaceuticals plc's latest earnings report can be listened to online.
The conference call transcript for Avadel Pharmaceuticals plc's latest earnings report can be read online.
Avadel Pharmaceuticals plc (:AVDL) has a recorded annual revenue of $169.12 M.
Avadel Pharmaceuticals plc (:AVDL) has a recorded net income of $-48,832,000.Avadel Pharmaceuticals plc has generated $-0.51 earnings per share over the last four quarters.
Avadel Pharmaceuticals plc (:AVDL) has a price-to-earnings ratio of -16.56 and price/earnings-to-growth ratio is -0.51.